课题基金 / 基金详情

Inhibitor of Normal Growth (ING)

Inhibitor of Normal Growth (ING)
正常生长抑制剂 (ING)
批准号:
7733297
负责人:
Curtis Harris
金额:
$64.86万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Curtis Harris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nutlin-3a, an inhibitor of murine double minute 2(MDM2), has the ability to activate p53, leading to p53-regulated processes such as apoptosis and cell growth arrest. We found that premature cellular senescence was a phenotype induced by Nutlin-3a-mediated activation of endogenouse p53 functions in normal human fibroblasts. The miR-34 families of microRNAs (miR-34a, miR-34b and miR-34c) were upregulated with the Nutlin-3a-induced senescence in a p53-dependent manner, suggesting the physiological importance of the endogenously expressed miR-34 family in the regulation of cellular senescence. Among the protein-coding genes which were altered in expression by Nutlin-3a, we selected ING2 for further study; a gene we studied previously. p53 directly bound to the ING2 gene promoter to transcriptionally repress it. The siRNA knockdown of ING2 induced cellular senescence as effectively as Nutlin-3a treatment in human fibroblasts. While the Nutlin-3a-induced senescence was p53-dependent, the ING2 knockdown caused senescence even in the abscence of p53, suggesting that ING2 is a downstream effector of Nutlin-3a-induced, p53-mediated signaling to cellular senescence. Two different facets of the functional interplay between p53 and ING2 in the regulation of senescence are suggested by our studies: (a) the enhanced activity of ING2 induces senescence by post-translationally activating p53; and (b) the endogenous levels of ING2 restricts senescence under non-stressed conditions without p53 activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
p53, Aging, and Cancer
  • 批准号:
    10486868
  • 项目类别:
  • 资助金额:
    $169.67万
  • 财政年份:
    --
  • 负责人:
    Curtis Harris
  • 依托单位:
Biomarkers of Human Lung Cancer
p53, Aging, and Cancer
  • 批准号:
    9343959
  • 项目类别:
  • 资助金额:
    $152.73万
  • 财政年份:
    --
  • 负责人:
    Curtis Harris
  • 依托单位:
p53, Aging, and Cancer
  • 批准号:
    10702577
  • 项目类别:
  • 资助金额:
    $187.35万
  • 财政年份:
    --
  • 负责人:
    Curtis Harris
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: